Outlook Therapeutics News, Outlook Therapeutics Quote, OTLK Quote

Outlook Therapeutics (NQ:OTLK) Delayed: 1.07 -0.34 (24.11%)

Prev. Close

$1.41

Today 6M 1Y 5Y

Open

$1.42

52 Wk High

$0.03

52 Wk Low

$0.01

Day High

$1.42

Day Low

$1.04

P/E

N/A

EPS

$0.00

Volume

40,335,489

Friends, Peers and Foes (?): OTLKW, ASML, BIDU, RH, SOC (more...)

ALERTS | RSS

Jul 27, 2026 06:09 AM BTIG Upgrades Outlook Therapeutics Inc. (OTLK) to Buy
Jul 24, 2026 05:01 PM Form 8-K Outlook Therapeutics, For: Jul 24
Jul 24, 2026 02:40 PM FDA approves Outlook Therapeutics' Lytenava for wet AMD
Jul 24, 2026 02:40 PM Outlook Therapeutics Announces LYTENAVA™ FDA Approval as the First and Only FDA-Approved Ophthalmic Bevacizumab for the Treatment of Wet AMD
Jul 24, 2026 01:40 PM Outlook Therapeutics (OTLK) halted, news pending
Jul 24, 2026 06:02 AM Form 8-K Outlook Therapeutics, For: Jul 21
Jul 23, 2026 07:50 PM Form 4 Outlook Therapeutics, For: Jul 21 Filed by: KENYON LAWRENCE A
Jul 23, 2026 07:34 PM Form 4 Outlook Therapeutics, For: Jul 21 Filed by: Jahr Robert Charles
Jul 22, 2026 06:05 AM Form EFFECT Outlook Therapeutics,
Jul 21, 2026 04:37 PM Form 424B3 Outlook Therapeutics,

Entities mentioned with OTLK

View All Entities